Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q3 2014 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GREEN PLAINS INC | 12 | Q3 2023 | 6.5% |
XERIS PHARMACEUTICALS INC | 12 | Q3 2023 | 0.3% |
ACORDA THERAPEUTICS INC | 11 | Q3 2023 | 1.0% |
TEAM INC | 11 | Q2 2023 | 0.9% |
CHESAPEAKE ENERGY CORP | 11 | Q3 2023 | 0.5% |
ISHARES TR | 10 | Q3 2023 | 49.6% |
GREEN PLAINS INC | 10 | Q3 2023 | 8.8% |
GREEN PLAINS INC | 9 | Q3 2023 | 6.2% |
NABORS INDS INC NEW | 9 | Q2 2023 | 2.0% |
TRAVERE THERAPEUTICS INC | 8 | Q3 2022 | 1.4% |
View Saltoro Capital, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR/A | 2022-08-17 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-12 |
View Saltoro Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.